|
C4ORF36 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.598000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.171360E-01 |
| Normal-vs-Stage2 |
3.804800E-01 |
| Normal-vs-Stage3 |
8.673800E-02 |
| Normal-vs-Stage4 |
2.793000E-01 |
| Stage1-vs-Stage2 |
8.442200E-01 |
| Stage1-vs-Stage3 |
3.810400E-01 |
| Stage1-vs-Stage4 |
7.941400E-01 |
| Stage2-vs-Stage3 |
4.661400E-01 |
| Stage2-vs-Stage4 |
7.258600E-01 |
| Stage3-vs-Stage4 |
7.814800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.210630E-01 |
| Normal-vs-AfricanAmerican |
6.403600E-02 |
| Normal-vs-Asian |
2.252000E-01 |
| Caucasian-vs-AfricanAmerican |
4.605800E-01 |
| Caucasian-vs-Asian |
4.593000E-01 |
| AfricanAmerican-vs-Asian |
6.082400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.896300E-02 |
| Normal-vs-Female |
2.848400E-01 |
| Male-vs-Female |
5.404400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.858300E-02 |
| Normal-vs-Extreme_Weight |
3.517700E-02 |
| Normal-vs-Obese |
4.822200E-01 |
| Normal-vs-Extreme_Obese |
6.757600E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.088800E-01 |
| Normal_Weight-vs-Obese |
1.413570E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.060000E-01 |
| Extreme_Weight-vs-Obese |
1.189630E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.963600E-01 |
| Obese-vs-Extreme_Obese |
1.559240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.850000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.458590E-01 |
| Normal-vs-Age(61-80Yrs) |
6.337700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.214300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.843970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.105640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.888100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.955800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.742500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.919010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.388400E-01 |
| Normal-VS-Type2 PRCC |
4.917100E-03 |
| Normal-VS-KIRP CIMP |
2.302000E-01 |
| Normal-VS-Unclassified PRCC |
1.255800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.795600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.199700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.092600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.614650E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.956760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.141900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.436500E-03 |
| Normal-vs-N1 |
3.660000E-01 |
| Normal-vs-N2 |
1.562820E-01 |
| N0-vs-N1 |
9.014000E-02 |
| N0-vs-N2 |
6.208000E-01 |
| N1-vs-N2 |
2.890400E-01 |
|
|
